UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.667

Sortiert nach

Genetic risk factors for variant Creutzfeldt–Jakob disease: a genome-wide association study

Lancet neurology, 2009, Vol.8 (1), p.57-66

2009

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series

Brain (London, England : 1878), 2008-10, Vol.131 (10), p.2632-2646

2008

Link zum Volltext

Verfügbarkeit prüfen

Inherited prion disease with six octapeptide repeat insertional mutation- : molecular analysis of phenotypic heterogeneity

Brain (London, England : 1878), 2006-09, Vol.129 (Pt 9), p.2297-2317

2006

Link zum Volltext

Verfügbarkeit prüfen

Inherited prion disease with 5-OPRI: phenotype modification by repeat length and codon 129

Neurology, 2007-08, Vol.69 (8), p.730

2007

Link zum Volltext

Verfügbarkeit prüfen

SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung

American journal of physiology. Lung cellular and molecular physiology, 2000-11, Vol.279 (5), p.895-L902

2000

Link zum Volltext

Verfügbarkeit prüfen

Intralesional Cytokines in Chronic Oxazolone-Induced Contact Sensitivity Suggest Roles for Tumor Necrosis Factor α and Interleukin-4

Journal of investigative dermatology, 1998-07, Vol.111 (1), p.86-92

1998

Link zum Volltext

Verfügbarkeit prüfen

First Report of Creutzfeldt-Jakob Disease Occurring in 2 Siblings Unexplained by PRNP Mutation

Journal of neuropathology and experimental neurology, 2008-09, Vol.67 (9), p.838-841

2008

Link zum Volltext

Verfügbarkeit prüfen

SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence

The Journal of pharmacology and experimental therapeutics, 2000-04, Vol.293 (1), p.281

2000

Link zum Volltext

Verfügbarkeit prüfen

Pyrimidinylimidazole inhibitors of CSBP/P38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes

Bioorganic & medicinal chemistry letters, 1998-11, Vol.8 (22), p.3111-3116

1998

Link zum Volltext

Verfügbarkeit prüfen

Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity

Bioorganic & medicinal chemistry letters, 2001-11, Vol.11 (21), p.2867-2870

2001

Link zum Volltext

Verfügbarkeit prüfen

Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation

The Journal of pharmacology and experimental therapeutics, 1994-02, Vol.268 (2), p.709

1994

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of contact sensitivity in human CD4+ transgenic mice by human CD4‐specific monoclonal antibodies: CD4+ T‐cell depletion is not required

Immunology, 2000-02, Vol.99 (2), p.287-295

2000

Link zum Volltext

Verfügbarkeit prüfen

Age of onset and death in inherited prion disease are heritable

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2009-06, Vol.150B (4), p.496-501

2009

Link zum Volltext

Verfügbarkeit prüfen

Bicyclic N-Hydroxyurea Inhibitors of 5-Lipoxygenase: Pharmacodynamic, Pharmacokinetic, and in Vitro Metabolic Studies Characterizing N-Hydroxy-N-(2,3-dihydro-6-(phenylmethoxy)-3-benzofuranyl)urea

Journal of medicinal chemistry, 1996-12, Vol.39 (26), p.5035-5046

1996

Link zum Volltext

Verfügbarkeit prüfen

'Dottyville'--Craiglockhart War Hospital and shell-shock treatment in the First World War

Journal of the Royal Society of Medicine, 2006-07, Vol.99 (7), p.342-346

Webb, T. E F

2006

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity

Prostaglandins, leukotrienes and essential fatty acids, 1999-07, Vol.61 (1), p.55-64

1999

Link zum Volltext

Verfügbarkeit prüfen

Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response

Inflammation, 1993-06, Vol.17 (3), p.333-344

1993

Link zum Volltext

Verfügbarkeit prüfen

Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist

The Journal of pharmacology and experimental therapeutics, 2000-10, Vol.295 (1), p.373

2000

Link zum Volltext

Verfügbarkeit prüfen

Induction of plasma exudation and inflammatory cell infiltration by leukotriene C4 and leukotriene B4 in mouse peritonitis

Inflammation, 1991-08, Vol.15 (4), p.251-258

1991

Link zum Volltext

Verfügbarkeit prüfen

Pyridinyl imidazoles inhibit the inflammatory phase of delayed type hypersensitivity reactions without affecting T-dependent immune responses

International journal of immunopharmacology, 1994-10, Vol.16 (10), p.795-804

1994

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of inflammatory cell infiltration by bicyclic imidazoles, SK&F 86002 and SK&F 104493

Inflammation, 1989-12, Vol.13 (6), p.727-739

1989

Link zum Volltext

Verfügbarkeit prüfen

Phlogistic activity of leukotriene D4 in the mouse

Inflammation, 1986-03, Vol.10 (1), p.1-7

1986

Link zum Volltext

Verfügbarkeit prüfen

Return to the Sea, Get Huge, Beat Cancer: An Analysis of Cetacean Genomes Including an Assembly for the Humpback Whale (Megaptera novaeangliae)

Molecular biology and evolution, 2019-08, Vol.36 (8), p.1746-1763

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology of the pyrroloimidazole, SK&F 105809—II: Antiinflammatory activity and inhibition of mediator production in vivo

Biochemical pharmacology, 1991-07, Vol.42 (4), p.825-831

1991

Link zum Volltext

Verfügbarkeit prüfen

SK&F 86002: A structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid

Biochemical pharmacology, 1987-10, Vol.36 (20), p.3463-3470

1987

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.667

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.293)
Mit Volltextzugriff
(2.337)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.652)
Life Sciences & Biomedicine
(1.125)
Humans
(840)
Female
(507)
Male
(478)
Biological And Medical Sciences
(461)
Physical Sciences
(445)
Medical Sciences
(343)
Animals
(308)
Adult
(278)
Middle Aged
(277)
Physics
(271)
Aged
(203)
Technology
(157)
Fundamental And Applied Biological Sciences. Psychology
(143)
General & Internal Medicine
(128)
Risk Factors
(128)
Adolescent
(127)
Astronomy & Astrophysics
(122)
Exact Sciences And Technology
(114)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Genetic risk factors for variant Creutzfeldt–Jakob disease: a genome-wide association study

Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series

Inherited prion disease with six octapeptide repeat insertional mutation- : molecular analysis of phenotypic heterogeneity

Inherited prion disease with 5-OPRI: phenotype modification by repeat length and codon 129

SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung

Intralesional Cytokines in Chronic Oxazolone-Induced Contact Sensitivity Suggest Roles for Tumor Necrosis Factor α and Interleukin-4

First Report of Creutzfeldt-Jakob Disease Occurring in 2 Siblings Unexplained by PRNP Mutation

SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence

Pyrimidinylimidazole inhibitors of CSBP/P38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes

Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity

Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation

Inhibition of contact sensitivity in human CD4+ transgenic mice by human CD4‐specific monoclonal antibodies: CD4+ T‐cell depletion is not required

Age of onset and death in inherited prion disease are heritable

Bicyclic N-Hydroxyurea Inhibitors of 5-Lipoxygenase: Pharmacodynamic, Pharmacokinetic, and in Vitro Metabolic Studies Characterizing N-Hydroxy-N-(2,3-dihydro-6-(phenylmethoxy)-3-benzofuranyl)urea

'Dottyville'--Craiglockhart War Hospital and shell-shock treatment in the First World War

In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity

Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response

Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist

Induction of plasma exudation and inflammatory cell infiltration by leukotriene C4 and leukotriene B4 in mouse peritonitis

Pyridinyl imidazoles inhibit the inflammatory phase of delayed type hypersensitivity reactions without affecting T-dependent immune responses

Inhibition of inflammatory cell infiltration by bicyclic imidazoles, SK&F 86002 and SK&F 104493

Phlogistic activity of leukotriene D4 in the mouse

Return to the Sea, Get Huge, Beat Cancer: An Analysis of Cetacean Genomes Including an Assembly for the Humpback Whale (Megaptera novaeangliae)

Pharmacology of the pyrroloimidazole, SK&F 105809—II: Antiinflammatory activity and inhibition of mediator production in vivo

SK&F 86002: A structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid

Suchergebnisse filtern